Global Kidney Disease Stem Cell Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032

January 2026 | 97 pages | ID: G3C0B66E3923EN
GlobalInfoResearch

Abstracts

According to our (Global Info Research) latest study, the global Kidney Disease Stem Cell Therapy market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.

The Kidney Disease Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Kidney Disease Stem Cell Therapy market is split by Type and by Application. For the period 2026-2032, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type,

• Autologous
• Allogeneic

Market segment by Application

• Preclinical
• Clinical Phase 1,2

Market segment by players, this report covers

• ProKidney
• Medi-post
• Anterogen
• Harvard Stem Cell Institute (HSCI)
• Medeor Therapeutics
• ProgenCell
• KidneyCure
• AlloCure
• Trestle Biotherapeutics
• Rege Nephro

Market segment by regions, regional analysis covers

North America
Europe
Asia-Pacific (China, Japan, South Korea, Rest of Asia)
South America
Middle East & Africa

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope of Kidney Disease Stem Cell Therapy
1.2 Classification of Kidney Disease Stem Cell Therapy by Type
  1.2.1 Overview: Global Kidney Disease Stem Cell Therapy Market Size by Type: 2026 Versus 2032
  1.2.2 Global Kidney Disease Stem Cell Therapy Revenue Market Share by Type in 2032
  1.2.3 Autologous
  1.2.4 Allogeneic
1.3 Global Kidney Disease Stem Cell Therapy Market by Application
  1.3.1 Overview: Global Kidney Disease Stem Cell Therapy Market Size by Application: 2026 Versus 2032
  1.3.2 Preclinical
  1.3.3 Clinical Phase 1,2
1.4 Global Kidney Disease Stem Cell Therapy Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
  1.5.1 Kidney Disease Stem Cell Therapy Market Drivers
  1.5.2 Kidney Disease Stem Cell Therapy Market Restraints
  1.5.3 Kidney Disease Stem Cell Therapy Trends Analysis

2 COMPANY PROFILES

2.1 ProKidney
  2.1.1 ProKidney Details
  2.1.2 ProKidney Major Business
  2.1.3 ProKidney Kidney Disease Stem Cell Therapy Product and Solutions
  2.1.4 ProKidney Recent Developments and Future Plans
2.2 Medi-post
  2.2.1 Medi-post Details
  2.2.2 Medi-post Major Business
  2.2.3 Medi-post Kidney Disease Stem Cell Therapy Product and Solutions
  2.2.4 Medi-post Recent Developments and Future Plans
2.3 Anterogen
  2.3.1 Anterogen Details
  2.3.2 Anterogen Major Business
  2.3.3 Anterogen Kidney Disease Stem Cell Therapy Product and Solutions
  2.3.4 Anterogen Recent Developments and Future Plans
2.4 Harvard Stem Cell Institute (HSCI)
  2.4.1 Harvard Stem Cell Institute (HSCI) Details
  2.4.2 Harvard Stem Cell Institute (HSCI) Major Business
  2.4.3 Harvard Stem Cell Institute (HSCI) Kidney Disease Stem Cell Therapy Product and Solutions
  2.4.4 Harvard Stem Cell Institute (HSCI) Recent Developments and Future Plans
2.5 Medeor Therapeutics
  2.5.1 Medeor Therapeutics Details
  2.5.2 Medeor Therapeutics Major Business
  2.5.3 Medeor Therapeutics Kidney Disease Stem Cell Therapy Product and Solutions
  2.5.4 Medeor Therapeutics Recent Developments and Future Plans
2.6 ProgenCell
  2.6.1 ProgenCell Details
  2.6.2 ProgenCell Major Business
  2.6.3 ProgenCell Kidney Disease Stem Cell Therapy Product and Solutions
  2.6.4 ProgenCell Recent Developments and Future Plans
2.7 KidneyCure
  2.7.1 KidneyCure Details
  2.7.2 KidneyCure Major Business
  2.7.3 KidneyCure Kidney Disease Stem Cell Therapy Product and Solutions
  2.7.4 KidneyCure Recent Developments and Future Plans
2.8 AlloCure
  2.8.1 AlloCure Details
  2.8.2 AlloCure Major Business
  2.8.3 AlloCure Kidney Disease Stem Cell Therapy Product and Solutions
  2.8.4 AlloCure Recent Developments and Future Plans
2.9 Trestle Biotherapeutics
  2.9.1 Trestle Biotherapeutics Details
  2.9.2 Trestle Biotherapeutics Major Business
  2.9.3 Trestle Biotherapeutics Kidney Disease Stem Cell Therapy Product and Solutions
  2.9.4 Trestle Biotherapeutics Recent Developments and Future Plans
2.10 Rege Nephro
  2.10.1 Rege Nephro Details
  2.10.2 Rege Nephro Major Business
  2.10.3 Rege Nephro Kidney Disease Stem Cell Therapy Product and Solutions
  2.10.4 Rege Nephro Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Kidney Disease Stem Cell Therapy Revenue and Share by Players (2026 & 2032)
3.2 Kidney Disease Stem Cell Therapy Players Head Office, Products and Services Provided
3.3 Kidney Disease Stem Cell Therapy Mergers & Acquisitions
3.4 Kidney Disease Stem Cell Therapy New Entrants and Expansion Plans

4 GLOBAL KIDNEY DISEASE STEM CELL THERAPY FORECAST BY REGION

4.1 Global Kidney Disease Stem Cell Therapy Market Size by Region: 2026 VS 2032
4.2 Global Kidney Disease Stem Cell Therapy Market Size by Region, (2026-2032)
4.3 North America
  4.3.1 Key Companies of Kidney Disease Stem Cell Therapy in North America
  4.3.2 Current Situation and Forecast of Kidney Disease Stem Cell Therapy in North America
  4.3.3 North America Kidney Disease Stem Cell Therapy Market Size and Prospect (2026-2032)
4.4 Europe
  4.4.1 Key Companies of Kidney Disease Stem Cell Therapy in Europe
  4.4.2 Current Situation and Forecast of Kidney Disease Stem Cell Therapy in Europe
  4.4.3 Europe Kidney Disease Stem Cell Therapy Market Size and Prospect (2026-2032)
4.5 Asia-Pacific
  4.5.1 Key Companies of Kidney Disease Stem Cell Therapy in Asia-Pacific
  4.5.2 Current Situation and Forecast of Kidney Disease Stem Cell Therapy in Asia-Pacific
  4.5.3 Asia-Pacific Kidney Disease Stem Cell Therapy Market Size and Prospect (2026-2032)
  4.5.4 China
  4.5.5 Japan
  4.5.6 South Korea
4.6 South America
  4.6.1 Key Companies of Kidney Disease Stem Cell Therapy in South America
  4.6.2 Current Situation and Forecast of Kidney Disease Stem Cell Therapy in South America
  4.6.3 South America Kidney Disease Stem Cell Therapy Market Size and Prospect (2026-2032)
4.7 Middle East & Africa
  4.7.1 Key Companies of Kidney Disease Stem Cell Therapy in Middle East & Africa
  4.7.2 Current Situation and Forecast of Kidney Disease Stem Cell Therapy in Middle East & Africa
  4.7.3 Middle East & Africa Kidney Disease Stem Cell Therapy Market Size and Prospect (2026-2032)

5 MARKET SIZE SEGMENT BY TYPE

5.1 Global Kidney Disease Stem Cell Therapy Market Forecast by Type (2026-2032)
5.2 Global Kidney Disease Stem Cell Therapy Market Share Forecast by Type (2026-2032)

6 MARKET SIZE SEGMENT BY APPLICATION

6.1 Global Kidney Disease Stem Cell Therapy Market Forecast by Application (2026-2032)
6.2 Global Kidney Disease Stem Cell Therapy Market Share Forecast by Application (2026-2032)

7 RESEARCH FINDINGS AND CONCLUSION

8 APPENDIX

8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Kidney Disease Stem Cell Therapy Revenue by Type, (USD Million) 2026 VS 2032
Table 2. Global Kidney Disease Stem Cell Therapy Revenue by Application, (USD Million), 2026 VS 2032
Table 3. ProKidney Corporate Information, Head Office, and Major Competitors
Table 4. ProKidney Major Business
Table 5. ProKidney Kidney Disease Stem Cell Therapy Product and Solutions
Table 6. Medi-post Corporate Information, Head Office, and Major Competitors
Table 7. Medi-post Major Business
Table 8. Medi-post Kidney Disease Stem Cell Therapy Product and Solutions
Table 9. Anterogen Corporate Information, Head Office, and Major Competitors
Table 10. Anterogen Major Business
Table 11. Anterogen Kidney Disease Stem Cell Therapy Product and Solutions
Table 12. Harvard Stem Cell Institute (HSCI) Corporate Information, Head Office, and Major Competitors
Table 13. Harvard Stem Cell Institute (HSCI) Major Business
Table 14. Harvard Stem Cell Institute (HSCI) Kidney Disease Stem Cell Therapy Product and Solutions
Table 15. Medeor Therapeutics Corporate Information, Head Office, and Major Competitors
Table 16. Medeor Therapeutics Major Business
Table 17. Medeor Therapeutics Kidney Disease Stem Cell Therapy Product and Solutions
Table 18. ProgenCell Corporate Information, Head Office, and Major Competitors
Table 19. ProgenCell Major Business
Table 20. ProgenCell Kidney Disease Stem Cell Therapy Product and Solutions
Table 21. KidneyCure Corporate Information, Head Office, and Major Competitors
Table 22. KidneyCure Major Business
Table 23. KidneyCure Kidney Disease Stem Cell Therapy Product and Solutions
Table 24. AlloCure Corporate Information, Head Office, and Major Competitors
Table 25. AlloCure Major Business
Table 26. AlloCure Kidney Disease Stem Cell Therapy Product and Solutions
Table 27. Trestle Biotherapeutics Corporate Information, Head Office, and Major Competitors
Table 28. Trestle Biotherapeutics Major Business
Table 29. Trestle Biotherapeutics Kidney Disease Stem Cell Therapy Product and Solutions
Table 30. Rege Nephro Corporate Information, Head Office, and Major Competitors
Table 31. Rege Nephro Major Business
Table 32. Rege Nephro Kidney Disease Stem Cell Therapy Product and Solutions
Table 33. Global Kidney Disease Stem Cell Therapy Revenue (USD Million) by Players (2026 & 2032)
Table 34. Global Kidney Disease Stem Cell Therapy Revenue Share by Players (2026 & 2032)
Table 35. Kidney Disease Stem Cell Therapy Players Head Office, Products and Services Provided
Table 36. Kidney Disease Stem Cell Therapy Mergers & Acquisitions in the Past Five Years
Table 37. Kidney Disease Stem Cell Therapy New Entrants and Expansion Plans
Table 38. Global Market Kidney Disease Stem Cell Therapy Revenue (USD Million) Comparison by Region (2026 VS 2032)
Table 39. Global Kidney Disease Stem Cell Therapy Revenue Market Share by Region (2026-2032)
Table 40. Key Companies of Kidney Disease Stem Cell Therapy in North America
Table 41. Current Situation and Forecast of Kidney Disease Stem Cell Therapy in North America
Table 42. Key Companies of Kidney Disease Stem Cell Therapy in Europe
Table 43. Current Situation and Forecast of Kidney Disease Stem Cell Therapy in Europe
Table 44. Key Companies of Kidney Disease Stem Cell Therapy in Asia-Pacific
Table 45. Current Situation and Forecast of Kidney Disease Stem Cell Therapy in Asia-Pacific
Table 46. Key Companies of Kidney Disease Stem Cell Therapy in China
Table 47. Key Companies of Kidney Disease Stem Cell Therapy in Japan
Table 48. Key Companies of Kidney Disease Stem Cell Therapy in South Korea
Table 49. Key Companies of Kidney Disease Stem Cell Therapy in South America
Table 50. Current Situation and Forecast of Kidney Disease Stem Cell Therapy in South America
Table 51. Key Companies of Kidney Disease Stem Cell Therapy in Middle East & Africa
Table 52. Current Situation and Forecast of Kidney Disease Stem Cell Therapy in Middle East & Africa
Table 53. Global Kidney Disease Stem Cell Therapy Revenue Forecast by Type (2026-2032)
Table 54. Global Kidney Disease Stem Cell Therapy Revenue Forecast by Application (2026-2032)

List Of Figures

LIST OF FIGURES

Figure 1. Kidney Disease Stem Cell Therapy Picture
Figure 2. Global Kidney Disease Stem Cell Therapy Revenue Market Share by Type in 2032
Figure 3. Autologous
Figure 4. Allogeneic
Figure 5. Kidney Disease Stem Cell Therapy Revenue Market Share by Application in 2032
Figure 6. Preclinical Picture
Figure 7. Clinical Phase 1,2 Picture
Figure 8. Global Kidney Disease Stem Cell Therapy Market Size, (USD Million): 2026 VS 2032
Figure 9. Global Kidney Disease Stem Cell Therapy Revenue and Forecast (2026-2032) & (USD Million)
Figure 10. Kidney Disease Stem Cell Therapy Market Drivers
Figure 11. Kidney Disease Stem Cell Therapy Market Restraints
Figure 12. Kidney Disease Stem Cell Therapy Market Trends
Figure 13. ProKidney Recent Developments and Future Plans
Figure 14. Medi-post Recent Developments and Future Plans
Figure 15. Anterogen Recent Developments and Future Plans
Figure 16. Harvard Stem Cell Institute (HSCI) Recent Developments and Future Plans
Figure 17. Medeor Therapeutics Recent Developments and Future Plans
Figure 18. ProgenCell Recent Developments and Future Plans
Figure 19. KidneyCure Recent Developments and Future Plans
Figure 20. AlloCure Recent Developments and Future Plans
Figure 21. Trestle Biotherapeutics Recent Developments and Future Plans
Figure 22. Rege Nephro Recent Developments and Future Plans
Figure 23. Global Kidney Disease Stem Cell Therapy Revenue Market Share by Region (2026-2032)
Figure 24. Global Kidney Disease Stem Cell Therapy Revenue Market Share by Region in 2032
Figure 25. North America Kidney Disease Stem Cell Therapy Revenue (USD Million) and Growth Rate (2026-2032)
Figure 26. Europe Kidney Disease Stem Cell Therapy Revenue (USD Million) and Growth Rate (2026-2032)
Figure 27. Asia-Pacific Kidney Disease Stem Cell Therapy Revenue (USD Million) and Growth Rate (2026-2032)
Figure 28. South America Kidney Disease Stem Cell Therapy Revenue (USD Million) and Growth Rate (2026-2032)
Figure 29. Middle East & Africa Kidney Disease Stem Cell Therapy Revenue (USD Million) and Growth Rate (2026-2032)
Figure 30. Global Kidney Disease Stem Cell Therapy Market Share Forecast by Type (2026-2032)
Figure 31. Global Kidney Disease Stem Cell Therapy Market Share Forecast by Application (2026-2032)
Figure 32. Methodology
Figure 33. Research Process and Data Source